Oxford Gene Technology (OGT), a provider of clinical genetics and diagnostic solutions, has announced that its next workshop will take place at this year's European Cytogenetics Conference.
Scheduled to take place during the event in Porto, Portugal, on 2-5 July, the workshop will feature a presentation from Prof Joris Vermeesch, head of the laboratory for cytogenetics and genome research at Katholieke Universiteit Leuven.
He will present data obtained using aCGH microarrays co-developed with OGT.
The presentation, entitled 'About inherited pathogenic and de novo benign CNVs', will cover the use of aCGH to deliver new insights into the association between copy-number variation and a range of developmental disorders.
Some of the data to be presented was obtained using a custom microarray that combines OGT's Cytosure ISCA 8 x 60k and Cytosure Syndrome Plus v2 2 x 105k arrays into a 4 x 180k format.
This design facilitates data sharing between ISCA consortium members and the comparison of new data with legacy data.
Additional data generated using this array was presented at the recent European Society of Human Genetics (ESHG) meeting in Amsterdam by Paul Brady, a PhD student in Vermeesch's lab.
This presentation, entitled 'The use of array CGH for prenatal diagnosis of foetuses with congenital malformations detected by ultrasound', is available to download on the OGT website.
Researchers at Katholieke Universiteit Leuven also recently utilised OGT Cytosure custom-designed arrays, Cytosure DNA labelling kits and Cytosure Interpret software to identify genomic imbalances associated with congenital diaphragmatic hernia (CDH), with the work subsequently published in the 'Prenatal Diagnosis' journal.
In addition, studies conducted at the university were instrumental in the development of the Cytosure Aneuploidy array, which is claimed to enable the simple, cost-effective detection of whole chromosomal imbalances in miscarriage samples.
